Simpler Grants.gov #NOT-CA-25-044

Forecasted Funding for NCI Community Oncology Research Program (NCORP) Academic Community Sites

The National Institutes of Health (NIH), through the National Cancer Institute (NCI), is forecasting a funding opportunity for the NCI Community Oncology Research Program (NCORP) Academic Community Sites. - Government Buyer: - National Institutes of Health (NIH), National Cancer Institute (NCI) - Program Overview: - Supports consortia of community hospitals, oncology practices, public hospitals, and academic medical centers - Focus on conducting studies in cancer control, prevention, treatment, and care delivery - Aims to improve the generalizability and dissemination of clinical trial results in diverse community settings - Participation Requirements: - Sites must accrue at least 70 new unique patients/participants annually - Accruals must be distributed across cancer control, prevention, screening/post-treatment surveillance, and treatment/imaging trials - Optional participation in cancer care delivery studies, with a minimum of 3 open protocols per year if participating - Funding Details: - Cooperative agreement mechanism - Expected program funding of $73,000,000 - Approximately 50 awards anticipated - No specific OEMs, vendors, or commercial products are referenced, as this is a grant opportunity for eligible institutions - Notable Requirements: - Emphasis on multi-institutional collaboration and meeting defined patient accrual targets - Participation in a broader NCORP initiative, which also includes Research Bases and Community Sites

Description

This Notice of Funding Opportunity (NOFO) from the National Cancer Institute (NCI) is part of the NCORP initiative aimed at enhancing the generalizability and dissemination of clinical trial results in community settings. It supports NCORP Academic Community Sites, which are consortia of community hospitals, oncology practices, public hospitals, and academic medical centers that serve diverse patient populations. These sites are expected to meet specific patient accrual targets across various cancer control, prevention, and treatment trials. The program fosters collaboration with NCORP Research Bases to improve clinical trial development and address care disparities.

View original listing